AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
R21 MALARIA ANTIGEN in Zimbabwe
2 products registered with MCAZ — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CYVAC SOLUTION; INJECTION | 2024/18.2/6711 | SERUM INSTITUTE OF INDIA PVT LTD | active | 31 Dec 2027 |
| CYVAC SOLUTION; INJECTION | 2024/18.2/6710 | SERUM INSTITUTE OF INDIA PVT LTD | active | 31 Dec 2027 |
R21 MALARIA ANTIGEN — MCAZ Registration Details
MCAZ (Zimbabwe) has 2 registered products containing R21 MALARIA ANTIGEN, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track R21 MALARIA ANTIGEN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.